The core findings of this study suggest that NMS in mice decreases DNA CpG methylation in the hepatic Cd36 promoter, increases hepatic Cd36 mRNA and protein levels, and causes NAFLD in adult male mice. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.